South African pharmaceutical company Aspen Pharmacare announced on Monday, December 29th, the sale of its main Asia-Pacific operations (excluding China) to Australian private equity fund BGH Capital for 2.37 billion Australian dollars, approximately 1.59 billion US dollars. This transaction, which includes markets in Australia, New Zealand, Hong Kong, Taiwan, Malaysia, and the Philippines, is part…...
Trending
- Op-ed SMRs in Africa After the World Bank’s Turnaround, Time for a New Financing Pact for Dispatchable Energy
- Guinea Bissau: Public Treasury raises 15 billion CFA francs on the UEMOA financial market
- Finance and African languages: Alassane Ba publishes the first French-Pulaar banking and financial lexicon
- Senegal and Benin: two trajectories, one same treatment
- Dr Donkor named recipient of prestigious distinguished African Development Finance Leadership Award.
- Burkina Faso: Diaspora Bond exceeds expectations with 151.5 billion CFA francs mobilized
- Morocco: Bank Al-Maghrib announces a overall stagnation of industrial activity in April 2026
- Infrastructure, Congo: MBTP at the heart of Central Africa’s most ambitious port project
